4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-035495
CEO & President sold 4,061 shares at $11.83 ($48,042)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cox John CEO & President | 2025-03-05 | Sale 10b5-1 | −4,061 | $11.83 | $48,042 | 146,239 | D |
| Open-market sales · 4,061 sh · avg $11.83 · $48,042 | |||||||
Loading xslF345X05/ownership.xml…